Testing effectiveness (Phase 2)Study completedNCT00062478
What this trial is testing
Study of Karenitecin (BNP1350) in Patients With Brain Tumors
Who this might be right for
Brain NeoplasmsMalignant Neoplasms, BrainBrain Tumors
BioNumerik Pharmaceuticals, Inc. 40